Long-term data of photoselective vaporization of the prostate (PVP) for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is scanty.
Evaluate the long-term efficacy and the complication rate in 80-watt (W) PVP.
Design, Setting, and Participants
500 consecutive patients with LUTS secondary to BPH underwent PVP between September 2002 and April 2007. The mean follow-up was 30.6
All patients underwent 80-W PVP performed by seven surgeons.
We evaluated perioperative parameters, including operation time, delivered energy, changes of hemoglobin and serum sodium, catheterization, and hospitalization time as well as intraoperative and postoperative complications. Patients presenting for follow-up had data assessed on the International Prostate Symptom Score and quality-of-life questionnaire (IPPS-QoL), maximal flow rate (Qmax), and post-voiding residual volume (Vres).
Results and Limitations
Mean patient age was 71.4
PVP is a safe and effective procedure for treatment of LUTS secondary to BPH. Patients on ongoing oral anticoagulation can be safely operated on. PVP leads to an immediate and sustained improvement of subjective and objective voiding parameters. The late complication rate is comparable to that of transurethral electroresection of the prostate.
Keywords: Benign prostatic hyperplasia, KTP laser, Photoselective vaporization, PVP, Long-term, GreenLight, BPH.
a Department of Urology, Basel University Hospital, Basel, Switzerland
b Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany
© 2008 European Association of Urology, Published by Elsevier B.V.